project id: TCGA-OV; case submitter id: TCGA-36-2533; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.7; spectrophotometer method: UV Spec; age at index: 55; days to birth: -20187; ethnicity: not reported; gender: female; race: not reported; vital status: Not Reported; year of birth: 1952; age at diagnosis: 20187; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 0.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.9; longest dimension: 1.0; preservation method: Unknown; shortest dimension: 0.4; sample id: 5ed1a91f-e14f-4220-a41e-f23ebd6cf72d; sample submitter id: TCGA-36-2533-01A; portion id: a2ad5f03-4ba4-4e60-966d-61ebb54aac53; portion submitter id: TCGA-36-2533-01A-01; percent normal cells: 0.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0;